Peptides Anti-Aging & LongevityHormone Support Preclinical (animal) data

Prostamax

4.1 hours

Half-life

0.5–2 mg

Typical dose

10–20 days per course, repeated 2–3× yearly (reported)

Cycle length

Peptide bioregulator researched for prostate tissue support.

Key takeaways

Synthetic prostate-targeted tetrapeptide (Lys-Glu-Asp-Pro) from the Khavinson bioregulator program.
Evidence is organotypic rat cultures and chromatin studies from one group; no human trials.
Plotter values are estimates modeled on similar short peptides, not measured human PK.
Reported 10–20 day courses are anecdotal; no established human dosing exists.

🚧 Expanded guide coming soon. This compound has PK data and a source — a full overview, mechanism, and dosing guide is pending editorial review.

Reported dosing protocols

Protocols reported in research literature and clinic/community use — informational context, not a dosing recommendation.

Use case	Dose	Route	Frequency	Duration
Prostate support (community)	1–2 mg	SubQ; oral capsules also sold	Once daily	10–20 days, repeated 2–3× yearly

Pharmacokinetic summary

Model tier: Simple (t½ + F, Tmax estimated)
Half-life: 4.1 hours
Bioavailability: 40%
Typical dose: 0.5–2 mg

Frequently asked questions

Can Prostamax help BPH or prostatitis?

No clinical evidence supports it. The data is rat tissue-culture work; no randomized trial in men with benign prostatic hyperplasia or prostatitis exists. Prostate symptoms warrant standard urological evaluation.

Is Prostamax a hormone or anti-androgen?

No. It's a short peptide claimed to regulate gene expression in prostate cells. No published work shows it binding androgen receptors or altering testosterone.

Has Prostamax been studied outside Russia?

Effectively no. The indexed literature comes from the originating institute and affiliated journals, with no independent Western replication.

References

Estimated (bioregulator) — Prostate-targeted peptide bioregulator.
Adv Gerontol 2006 — tissue-specific peptides in organotypic tissue culture — Prostamax stimulated aged rat prostate explants at 0.05 ng/mL; single-group preclinical work.
Georgian Med News 2012 — KEDP-induced chromatin deheterochromatinization — Mechanistic chromatin study of the Prostamax sequence (Lys-Glu-Asp-Pro) in human lymphocytes.

Comments

Loading comments…